{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:29Z","timestamp":1787016929154,"version":"build-2736575974"},"reference-count":26,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,10,31]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study was conducted with the aim of assessing the correlation between highly sensitive C reactive protein (hsCRP) levels and indicators of disability and functional impairment in individuals presenting with acute ischaemic stroke (AIS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Department of General Medicine at the All India Institute of Medical Sciences, Patna, Eastern India from August 2022 to August 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The study population comprised a total of 125 patients aged 18 years or more, presenting within 48 hours of symptom onset or time last known well and having confirmed ischaemic stroke through CT or MRI of the brain. Individuals with a history of prior stroke, other neurological disorders, active infections, known coronary artery disease, chronic kidney disease, chronic liver disease and abnormal blood cell counts were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Modified Rankin scale (mRS) and Barthel Index (BI) scores on day 2 and day 5 were the primary outcome measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The hsCRP levels on day 2 and day 5 were significantly positively correlated with the National Institutes of Health Stroke Scale scores with Spearman\u2019s rho 0.303 (p=0.001) and 0.386 (p&lt;0.001), respectively. The hsCRP on day 2 exhibited a significant association with mRS scores (p=0.04), indicating disability, but this significance was not sustained on day 5 (p=0.125). A negative correlation was observed between hsCRP and BI scores on both day 2 (Spearman\u2019s rho=\u22120.265, p=0.003) and day 5 (Spearman\u2019s rho=\u22120.297, p=0.002). While the hsCRP levels on day 2 did not differ significantly between fatal and non-fatal cases (p=0.110), the hsCRP levels on day 5 were significantly higher in fatal cases (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study underscores the potential utility of hsCRP as a prognostic indicator in patients with AIS. Elevated hsCRP levels correlated with increased stroke severity and functional disability. Regular assessments of hsCRP in the early phase of AIS could contribute to predicting prognosis and guiding optimal patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-085078","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T02:07:00Z","timestamp":1732846020000},"page":"e085078","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Can high-sensitivity C reactive protein (hsCRP) be used as a prognostic marker of functional disability after acute ischaemic stroke? A cross-sectional study at a tertiary care centre in Eastern India"],"prefix":"10.1136","volume":"14","author":[{"given":"Kotha","family":"Vamshikrishnapatel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-4459","authenticated-orcid":false,"given":"Ratnadeep","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-7784","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-9073","authenticated-orcid":false,"given":"Vishnu Shankar","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"2024121219443923000_14.11.e085078.1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027044","article-title":"Burden of Stroke and Population-Attributable Fractions of Risk Factors in Latin America and the Caribbean","volume":"11","author":"Pacheco-Barrios","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024121219443923000_14.11.e085078.2","unstructured":"Tadi P , Lui F . Acute stroke. Treasure Island (FL): StatPearls Publishing, 2023."},{"key":"2024121219443923000_14.11.e085078.3","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2024121219443923000_14.11.e085078.4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207609","article-title":"Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives","volume":"21","author":"Kuriakose","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024121219443923000_14.11.e085078.5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"2024121219443923000_14.11.e085078.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive Protein at Sites of Inflammation and Infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"key":"2024121219443923000_14.11.e085078.7","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"key":"2024121219443923000_14.11.e085078.8","first-page":"166","article-title":"Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?","volume":"29","author":"Taheraghdam","year":"2013","journal-title":"Pak J Med Sci"},{"key":"2024121219443923000_14.11.e085078.9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000321415","article-title":"Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke?","volume":"64","author":"Song","year":"2010","journal-title":"Eur Neurol"},{"key":"2024121219443923000_14.11.e085078.10","first-page":"92","article-title":"High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center","volume":"12","author":"Chaudhuri","year":"2013","journal-title":"Iran J Neurol"},{"key":"2024121219443923000_14.11.e085078.11","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.015434"},{"key":"2024121219443923000_14.11.e085078.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000258355.23810.c6"},{"key":"2024121219443923000_14.11.e085078.13","doi-asserted-by":"publisher","DOI":"10.3109\/09638288809164103"},{"key":"2024121219443923000_14.11.e085078.14","unstructured":"Barthel Index . Physiopedia. n.d. Available: https:\/\/www.physio-pedia.com\/Barthel_Index"},{"key":"2024121219443923000_14.11.e085078.15","article-title":"Validity of National Institutes of Health Stroke Scale for Severity of Stroke to Predict Mortality Among Patients Presenting With Symptoms of Stroke","volume":"12","author":"Farooque","year":"2020","journal-title":"Cureus"},{"key":"2024121219443923000_14.11.e085078.16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.18203\/2349-3933.ijam20182006","article-title":"Prognostic significance of hs-CRP in acute ischemic stroke patients","volume":"5","author":"Pandey","year":"2018","journal-title":"Int J Adv Med"},{"key":"2024121219443923000_14.11.e085078.17","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/857484","article-title":"Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective","volume":"2011","author":"Di Napoli","year":"2011","journal-title":"J Aging Res"},{"key":"2024121219443923000_14.11.e085078.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02489.x"},{"key":"2024121219443923000_14.11.e085078.19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature New Biol"},{"key":"2024121219443923000_14.11.e085078.20","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12227"},{"key":"2024121219443923000_14.11.e085078.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0866-y"},{"key":"2024121219443923000_14.11.e085078.22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3892\/etm.2015.2672","article-title":"Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy","volume":"10","author":"Ye","year":"2015","journal-title":"Exp Ther Med"},{"key":"2024121219443923000_14.11.e085078.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104054","article-title":"Association between high-sensitivity C-reactive protein, functional disability, and stroke recurrence in patients with acute ischaemic stroke: A mediation analysis","volume":"80","author":"Gu","year":"2022","journal-title":"EBioMedicine"},{"key":"2024121219443923000_14.11.e085078.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00430","article-title":"C-Reactive Protein in Atherothrombosis and Angiogenesis","volume":"9","author":"Badimon","year":"2018","journal-title":"Front Immunol"},{"key":"2024121219443923000_14.11.e085078.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.4.917"},{"key":"2024121219443923000_14.11.e085078.26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/br.2023.1599","article-title":"CRP as a potential predictor of outcome in acute ischemic stroke","volume":"18","author":"Bian","year":"2023","journal-title":"Biomed Rep"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-085078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T23:09:51Z","timestamp":1734044991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-085078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,28]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjopen-2024-085078"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085078","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}